Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Evelo Biosciences Inc

(NASDAQ: EVLO)
Add to Portfolio
+0.28 (+4.37%)
as of Oct 16, 2019

Evelo Biosciences to Present at the 2019 Cantor Global

GlobeNewswire via COMTEX - Thu Sep 26, 04:05PM EDT
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing orally delivered, systemically acting biologics, today announced that management will present a corporate overview at the 2019 Cantor Global (full story)
EVLO: 6.69 (+0.28)

Evelo Biosciences to Host Key Opinion Leader Symposium

GlobeNewswire via COMTEX - Fri Sep 20, 07:00AM EDT
Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing orally delivered, systemically acting biologics, today announced that it will host a key opinion leader symposium on the unmet need in mild (full story)
EVLO: 6.69 (+0.28)

Evelo Biosciences Announces the Appointment of David

GlobeNewswire via COMTEX - Tue Sep 17, 07:01AM EDT
Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing orally delivered, systemically acting biologics, announced today that David Epstein has been appointed chairman of its Board of Directors. M(full story)
EVLO: 6.69 (+0.28)

Evelo Biosciences to Present at the Morgan Stanley

GlobeNewswire via COMTEX - Wed Sep 04, 07:27PM EDT
Evelo Biosciences, Inc. (Nasdaq:EVLO), a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects, today announced that management will participate in a fireside ch(full story)
MS: 42.79 (+0.26), EVLO: 6.69 (+0.28)

Evelo Biosciences Reports Positive EDP1815 Interim

GlobeNewswire via COMTEX - Tue Aug 06, 07:05AM EDT
-EDP1815 was Well Tolerated with No Overall Difference Reported from Placebo-(full story)
EVLO: 6.69 (+0.28)